![Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants](https://www.mdpi.com/vaccines/vaccines-10-01655/article_deploy/html/images/vaccines-10-01655-g001.png)
Vaccines | Free Full-Text | A Comprehensive Review on the Current Vaccines and Their Efficacies to Combat SARS-CoV-2 Variants
![Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41541-022-00583-w/MediaObjects/41541_2022_583_Fig1_HTML.png)
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
![Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.5b00711/asset/images/medium/pr-2015-00711n_0008.gif)
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
![Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-023-37926-7/MediaObjects/41467_2023_37926_Fig1_HTML.png)
Inactivated vaccine-elicited potent antibodies can broadly neutralize SARS-CoV-2 circulating variants | Nature Communications
![A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs | Cell Research A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs | Cell Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41422-022-00612-2/MediaObjects/41422_2022_612_Fig1_HTML.png)
A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs | Cell Research
![Vaccines | Free Full-Text | Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy Vaccines | Free Full-Text | Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy](https://www.mdpi.com/vaccines/vaccines-09-01195/article_deploy/html/images/vaccines-09-01195-g001.png)
Vaccines | Free Full-Text | Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
![Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41541-022-00583-w/MediaObjects/41541_2022_583_Fig6_HTML.png)
Transcriptome signatures preceding the induction of anti-stalk antibodies elicited after universal influenza vaccination | npj Vaccines
![Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-80896-9/MediaObjects/41598_2020_80896_Fig1_HTML.png)
Antiviral activity of lambda-carrageenan against influenza viruses and severe acute respiratory syndrome coronavirus 2 | Scientific Reports
![Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012250-gr2.jpg)
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
![Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster - eBioMedicine Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster - eBioMedicine](https://www.thelancet.com/cms/attachment/4d931bc2-a51c-4bca-b7b6-343141312cd9/gr1.jpg)
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster - eBioMedicine
![Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124721012250-fx1.jpg)
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses - ScienceDirect
![COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine](https://www.thelancet.com/cms/attachment/17735a9b-6510-4802-9267-f56261f3daf9/gr1_lrg.jpg)
COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2 - eClinicalMedicine
![The evolutionary and functional significance of germline immunoglobulin gene variation: Trends in Immunology The evolutionary and functional significance of germline immunoglobulin gene variation: Trends in Immunology](https://www.cell.com/cms/attachment/a729f3af-e643-4c23-bb71-5b8f6e50b3a3/gr1_lrg.jpg)
The evolutionary and functional significance of germline immunoglobulin gene variation: Trends in Immunology
![mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron - ScienceDirect mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2211124722004326-fx1.jpg)
mRNA vaccination in octogenarians 15 and 20 months after recovery from COVID-19 elicits robust immune and antibody responses that include Omicron - ScienceDirect
![Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations | Genes & Immunity Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations | Genes & Immunity](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41435-021-00143-7/MediaObjects/41435_2021_143_Fig1_HTML.png)
Population matched (pm) germline allelic variants of immunoglobulin (IG) loci: Relevance in infectious diseases and vaccination studies in human populations | Genes & Immunity
![Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond - ScienceDirect Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2589004222017795-fx1.jpg)
Enhanced virulence and waning vaccine-elicited antibodies account for breakthrough infections caused by SARS-CoV-2 delta and beyond - ScienceDirect
![Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera - ScienceDirect Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867421002221-fx1.jpg)
Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera - ScienceDirect
![Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults | Nature Aging Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults | Nature Aging](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs43587-022-00292-y/MediaObjects/43587_2022_292_Fig1_HTML.png)
Signs of immunosenescence correlate with poor outcome of mRNA COVID-19 vaccination in older adults | Nature Aging
![Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children - Turner - 2020 - Clinical & Experimental Immunology - Wiley Online Library Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children - Turner - 2020 - Clinical & Experimental Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/898a5668-0854-48ee-b9f9-52a2ddd4794c/cei13395-fig-0001-m.jpg)
Differences in nasal immunoglobulin A responses to influenza vaccine strains after live attenuated influenza vaccine (LAIV) immunization in children - Turner - 2020 - Clinical & Experimental Immunology - Wiley Online Library
![Vaccines | Free Full-Text | Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness Vaccines | Free Full-Text | Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness](https://www.mdpi.com/vaccines/vaccines-10-01751/article_deploy/html/images/vaccines-10-01751-g001.png)
Vaccines | Free Full-Text | Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
![Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research](https://pubs.acs.org/cms/10.1021/acs.jproteome.5b00711/asset/images/medium/pr-2015-00711n_0002.gif)
Subset of Kappa and Lambda Germline Sequences Result in Light Chains with a Higher Molecular Mass Phenotype | Journal of Proteome Research
![Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525001617305944-fx1.jpg)
Self-Amplifying RNA Vaccines Give Equivalent Protection against Influenza to mRNA Vaccines but at Much Lower Doses - ScienceDirect
![Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications Sequence signatures of two public antibody clonotypes that bind SARS-CoV-2 receptor binding domain | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-24123-7/MediaObjects/41467_2021_24123_Fig1_HTML.png)